# Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

> **NCT02324621** · PHASE1 · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 26 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor

## Interventions

- **DRUG:** Oral ONC201
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02324621
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-20
- **Primary completion:** 2018-10-18
- **Final completion:** 2018-10-23
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324621, "Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02324621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*